329 related articles for article (PubMed ID: 25136857)
1. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
Koshiar RL; Somajo S; Norström E; Dahlbäck B
PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
[TBL] [Abstract][Full Text] [Related]
2. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
Somajo S; Koshiar RL; Norström E; Dahlbäck B
Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
[TBL] [Abstract][Full Text] [Related]
4. Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.
Stavenuiter F; Davis NF; Duan E; Gale AJ; Heeb MJ
Thromb Haemost; 2013 Feb; 109(2):229-37. PubMed ID: 23238804
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
van 't Veer C; Golden NJ; Kalafatis M; Mann KG
J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.
Tans G; Rosing J; Thomassen MC; Heeb MJ; Zwaal RF; Griffin JH
Blood; 1991 Jun; 77(12):2641-8. PubMed ID: 2043766
[TBL] [Abstract][Full Text] [Related]
9. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
[TBL] [Abstract][Full Text] [Related]
10. [Coagulation properties of erythrocyte derived membrane microparticles].
Antonova OA; Shustova ON; Golubeva NV; Yakushkin VV; Alchinova IB; Karganov MY; Mazurov AV
Biomed Khim; 2019 Apr; 65(3):214-221. PubMed ID: 31258144
[TBL] [Abstract][Full Text] [Related]
11. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Cramer TJ; Griffin JH; Gale AJ
Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
[TBL] [Abstract][Full Text] [Related]
12. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
[TBL] [Abstract][Full Text] [Related]
13. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT.
Connor DE; Exner T; Ma DD; Joseph JE
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):558-64. PubMed ID: 19593114
[TBL] [Abstract][Full Text] [Related]
14. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
15. Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release.
Fu Y; Zhou J; Li H; Cao F; Su Y; Fan S; Li Y; Wang S; Li L; Gilbert GE; Shi J
Thromb Haemost; 2010 Dec; 104(6):1235-41. PubMed ID: 20886178
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
17. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
18. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
19. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease.
He Z; Si Y; Jiang T; Ma R; Zhang Y; Cao M; Li T; Yao Z; Zhao L; Fang S; Yu B; Dong Z; Thatte HS; Bi Y; Kou J; Yang S; Piao D; Hao L; Zhou J; Shi J
Thromb Haemost; 2016 Apr; 115(4):738-51. PubMed ID: 26660948
[TBL] [Abstract][Full Text] [Related]
20. Use of Thrombodynamics for revealing the participation of platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation.
Lipets EN; Antonova OA; Shustova ON; Losenkova KV; Mazurov AV; Ataullakhanov FI
PLoS One; 2020; 15(5):e0227932. PubMed ID: 32469873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
